Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tomas Carrascosa Vallejo"'
Autor:
Jose Enrique De La Puerta Rueda, Isabel Uriarte, Paula Arana Berganza, Natalia Maruri Machado, Itxaso Amarika Ibarrondo, Begoña Sancho Garaizábal, Tomas Carrascosa Vallejo, Iñigo Vicente Olabarria, Cristina Martinez Bilbao, Alberto Cabrera Zubizarreta, Cristina Cortes Fernández, Clara Gómez Pérez, Ane Aranbarri Chamorro, Maria Jose Ereño Ealo, José María Ontañón Garcés, Elixabete Pastor Ausin, Alberto Saiz López, Ibone Saralegui Prieto, Eukene Gainza González, Jesus Ojanguren Bergaz, Eloisa Urrechaga Igartua, Concepción Rodríguez, Inmaculada Barredo Santamaría, Garazi Letamendi Madariaga, Ianire Etxeguren Urkixo, Javier Goikolea Ugarte, Inés González Vallejo, Marta Alonso Varela, Urko Aguirre Larracoechea, Paloma Ibarrondo Chamorro, Matxalen Olivares Salaverri, Amaia Casado Diez, Amaia Sierra Zabala, Miriam Bustos Martínez, Raquel Pérez Garay
Publikováno v:
Blood. 136:43-44
BACKGROUND Current treatment choices are based on generalized outcome data from clinical trials, but not all MM patients respond the same and a considerable percentage of them do not achieve a desirable treatment endpoint. Contradictory results based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2949d72ea8722d9b9df08d9dbb388197
https://doi.org/10.1182/blood-2020-138555
https://doi.org/10.1182/blood-2020-138555
Autor:
Alberto Saiz López, Alberto Cabrera Zubizarreta, Tomas Carrascosa Vallejo, Raquel Pérez Garay, Maria Jose Ereño Ealo, Cristina Cortes Fernández, Ana de Juan Arroyo, Jose Enrique De La Puerta Rueda, Javier Goikolea Ugarte, Ibone Saralegui Prieto, Mara Celis Alvarez, Isabel Uriarte, Amaia Casado Diez, Paula Arana Berganza, Natalia Maruri Machado, Paloma Ibarrondo Chamorro, Inmaculada Barredo Santamaría, Eukene Gainza González, Cristina Martinez Bilbao, Elixabete Pastor Ausin, Luis Atutxa Aresti, Eloisa Urrechaga Igartua, Leire Burgos, José María Ontañón Garcés, Bruno Paiva, Matxalen Olivares Salaverri, Begoña Sancho Garaizábal, Iñigo Vicente Olabarria, Garazi Letamendi Madariaga, Ane Aranbarri Larrañaga, Ianire Etxeguren Urkixo, Inés González Vallejo, Antonio Rodríguez, Estibalitz Montejo Rodrigo, Itxaso Amarika Ibarrondo, Jesus Ojanguren Bergaz
Publikováno v:
Blood. 134:3170-3170
Background: Assessing MRD has become a standard procedure in clinical trials to evaluate treatment efficacy. In accordance with its consistent prognostic value, the International Myeloma Working Group added MRD-negative criteria into response guideli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b73f8dc58f79f257a48ff1f86b893b0b
https://doi.org/10.1182/blood-2019-125062
https://doi.org/10.1182/blood-2019-125062